http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3887705-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6fe9e449ae407658416f55e6e1a20db8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-335
filingDate 1973-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1975-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_484081935fb74d9329eed97a87147fa2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ad7db1d3629c223f82a2e545c3bda33
publicationDate 1975-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-3887705-A
titleOfInvention Medicaments intended for the prevention and treatment of capillary-venous deficiencies
abstract The present invention relates to new compositions which are useful as medicaments. These new compositions contain dihydroergotamine, one or more vitamin P factors and a vitamin C factor. They are useful in the prevention and treatment of disturbances of the vein wall, particularly the orthostatic syndrome.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5069911-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8706128-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006183779-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003181488-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006030620-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4366145-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5162303-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8909599-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4167562-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4929640-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9925174-B2
priorityDate 1972-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280805
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507743
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6436550
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6426689
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281416
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585185
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743199
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24832108
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426106947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451839851
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426088935
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419515267
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412027
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10621
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546720
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503510
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54670067
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226429103
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534376
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226429104
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23683938
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7189
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260394
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10531
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54690252
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71171
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5486699
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743273
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447508948
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452579258

Total number of triples: 58.